Literature DB >> 21097509

Altered immune response in mice deficient for the G protein-coupled receptor GPR34.

Ines Liebscher1, Uwe Müller, Daniel Teupser, Eva Engemaier, Kathrin M Y Engel, Lars Ritscher, Doreen Thor, Katrin Sangkuhl, Albert Ricken, Antje Wurm, Daniel Piehler, Sandra Schmutzler, Herbert Fuhrmann, Frank W Albert, Andreas Reichenbach, Joachim Thiery, Torsten Schöneberg, Angela Schulz.   

Abstract

The X-chromosomal GPR34 gene encodes an orphan G(i) protein-coupled receptor that is highly conserved among vertebrates. To evaluate the physiological relevance of GPR34, we generated a GPR34-deficient mouse line. GPR34-deficient mice were vital, reproduced normally, and showed no gross abnormalities in anatomical, histological, laboratory chemistry, or behavioral investigations under standard housing. Because GPR34 is highly expressed in mononuclear cells of the immune system, mice were specifically tested for altered functions of these cell types. Following immunization with methylated BSA, the number of granulocytes and macrophages in spleens was significantly lower in GPR34-deficient mice as in wild-type mice. GPR34-deficient mice showed significantly increased paw swelling in the delayed type hypersensitivity test and higher pathogen burden in extrapulmonary tissues after pulmonary infection with Cryptococcus neoformans compared with wild-type mice. The findings in delayed type hypersensitivity and infection tests were accompanied by significantly different basal and stimulated TNF-α, GM-CSF, and IFN-γ levels in GPR34-deficient animals. Our data point toward a functional role of GPR34 in the cellular response to immunological challenges.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21097509      PMCID: PMC3023507          DOI: 10.1074/jbc.M110.196659

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment.

Authors:  D C Rogers; E M Fisher; S D Brown; J Peters; A J Hunter; J E Martin
Journal:  Mamm Genome       Date:  1997-10       Impact factor: 2.957

Review 2.  Orphan seven transmembrane receptor screening.

Authors:  M J Wigglesworth; L A Wolfe; A Wise
Journal:  Ernst Schering Found Symp Proc       Date:  2006

3.  Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs.

Authors:  C J Foster; D M Prosser; J M Agans; Y Zhai; M D Smith; J E Lachowicz; F L Zhang; E Gustafson; F J Monsma; M T Wiekowski; S J Abbondanzo; D N Cook; M L Bayne; S A Lira; M S Chintala
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

4.  IL-1beta, but not IL-1alpha, is required for antigen-specific T cell activation and the induction of local inflammation in the delayed-type hypersensitivity responses.

Authors:  Aya Nambu; Susumu Nakae; Yoichiro Iwakura
Journal:  Int Immunol       Date:  2006-03-28       Impact factor: 4.823

Review 5.  Delayed type hypersensitivity: current theories with an historic perspective.

Authors:  C A Black
Journal:  Dermatol Online J       Date:  1999-05

6.  A G protein-coupled receptor for UDP-glucose.

Authors:  J K Chambers; L E Macdonald; H M Sarau; R S Ames; K Freeman; J J Foley; Y Zhu; M M McLaughlin; P Murdock; L McMillan; J Trill; A Swift; N Aiyar; P Taylor; L Vawter; S Naheed; P Szekeres; G Hervieu; C Scott; J M Watson; A J Murphy; E Duzic; C Klein; D J Bergsma; S Wilson; G P Livi
Journal:  J Biol Chem       Date:  2000-04-14       Impact factor: 5.157

7.  Lysophosphatidylserine stimulates leukemic cells but not normal leukocytes.

Authors:  Kyoung Sun Park; Ha Young Lee; Mi-Kyoung Kim; Eun Ha Shin; Yoe-Sik Bae
Journal:  Biochem Biophys Res Commun       Date:  2005-07-29       Impact factor: 3.575

8.  IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans.

Authors:  Uwe Müller; Werner Stenzel; Gabriele Köhler; Christoph Werner; Tobias Polte; Gesine Hansen; Nicole Schütze; Reinhard K Straubinger; Manfred Blessing; Andrew N J McKenzie; Frank Brombacher; Gottfried Alber
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

9.  The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints.

Authors:  Robert Fredriksson; Malin C Lagerström; Lars-Gustav Lundin; Helgi B Schiöth
Journal:  Mol Pharmacol       Date:  2003-06       Impact factor: 4.436

Review 10.  Appearances can be deceiving: phenotypes of knockout mice.

Authors:  Ivana Barbaric; Gaynor Miller; T Neil Dear
Journal:  Brief Funct Genomic Proteomic       Date:  2007-06-20
View more
  26 in total

Review 1.  Identifying ligands at orphan GPCRs: current status using structure-based approaches.

Authors:  Tony Ngo; Irina Kufareva; James Lj Coleman; Robert M Graham; Ruben Abagyan; Nicola J Smith
Journal:  Br J Pharmacol       Date:  2016-03-05       Impact factor: 8.739

2.  G protein-coupled receptor 34 in ovarian granulosa cells of cattle: changes during follicular development and potential functional implications.

Authors:  L J Spicer; L F Schütz; J A Williams; N B Schreiber; J R Evans; M L Totty; J N Gilliam
Journal:  Domest Anim Endocrinol       Date:  2016-12-11       Impact factor: 2.290

3.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 4.  Hunting for the function of orphan GPCRs - beyond the search for the endogenous ligand.

Authors:  Raise Ahmad; Stefanie Wojciech; Ralf Jockers
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

5.  t(X;14)(p11.4;q32.33) is recurrent in marginal zone lymphoma and up-regulates GPR34.

Authors:  Mathijs Baens; Julio Finalet Ferreiro; Thomas Tousseyn; Helena Urbankova; Lucienne Michaux; Laurence de Leval; Daan Dierickx; Pascal Wolter; Xavier Sagaert; Peter Vandenberghe; Christiane De Wolf-Peeters; Iwona Wlodarska
Journal:  Haematologica       Date:  2011-11-04       Impact factor: 9.941

Review 6.  Lysophospholipid receptor nomenclature review: IUPHAR Review 8.

Authors:  Yasuyuki Kihara; Michael Maceyka; Sarah Spiegel; Jerold Chun
Journal:  Br J Pharmacol       Date:  2014-07-12       Impact factor: 8.739

Review 7.  Emerging roles for lysophosphatidylserine in resolution of inflammation.

Authors:  S Courtney Frasch; Donna L Bratton
Journal:  Prog Lipid Res       Date:  2012-03-29       Impact factor: 16.195

8.  t(X;14)(p11;q32) in MALT lymphoma involving GPR34 reveals a role for GPR34 in tumor cell growth.

Authors:  Stephen M Ansell; Takashi Akasaka; Ellen McPhail; Michelle Manske; Esteban Braggio; Tammy Price-Troska; Steven Ziesmer; Frank Secreto; Rafael Fonseca; Mamta Gupta; Mark Law; Thomas E Witzig; Martin J S Dyer; Ahmet Dogan; James R Cerhan; Anne J Novak
Journal:  Blood       Date:  2012-09-10       Impact factor: 22.113

9.  TGFα shedding assay: an accurate and versatile method for detecting GPCR activation.

Authors:  Asuka Inoue; Jun Ishiguro; Hajime Kitamura; Naoaki Arima; Michiyo Okutani; Akira Shuto; Shigeki Higashiyama; Tomohiko Ohwada; Hiroyuki Arai; Kumiko Makide; Junken Aoki
Journal:  Nat Methods       Date:  2012-09-16       Impact factor: 28.547

Review 10.  The Lysophosphatidylserines-An Emerging Class of Signalling Lysophospholipids.

Authors:  Karthik Shanbhag; Amol Mhetre; Neha Khandelwal; Siddhesh S Kamat
Journal:  J Membr Biol       Date:  2020-08-07       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.